Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Nasdaq

iSun’s Final Chapter: Liquidation Wipes Out Shareholder Value

Felix Baarz by Felix Baarz
November 15, 2025
in Nasdaq, Penny Stocks, Renewable Energy
0
iSun Stock
0
SHARES
110
VIEWS
Share on FacebookShare on Twitter

The corporate saga of iSun has reached its definitive conclusion, with the former solar energy firm now undergoing complete liquidation. Investors face total losses as the company’s bankruptcy proceedings transitioned from reorganization to Chapter 7, marking the final stage of its corporate existence.

From NASDAQ to Oblivion: A Timeline of Collapse

iSun, Inc. initiated Chapter 11 bankruptcy protection in June 2024, triggering immediate suspension of its NASDAQ trading privileges. The U.S. Securities and Exchange Commission formally revoked the company’s listing approval on May 23, 2024. Since that date, the equity has traded exclusively over-the-counter under the symbol ISUNQ, with minimal trading activity reflecting the company’s dire financial condition.

The decisive turning point arrived on January 27, 2025, when the bankruptcy case converted from Chapter 11 reorganization to Chapter 7 liquidation. This legal shift represents the point of no return—instead of attempting business recovery, the company will now be systematically dismantled.

Key milestones in the decline:
* Chapter 11 bankruptcy filing: June 2024
* NASDAQ delisting: May 23, 2024
* Conversion to Chapter 7: January 27, 2025
* Asset sale approval: August 23, 2024

Should investors sell immediately? Or is it worth buying iSun?

Asset Transfer and Corporate Rebranding

A Siltstone Capital affiliate purchased iSun’s remaining operational assets for just $10 million, receiving bankruptcy court authorization on August 23, 2024. This transaction transferred the company’s business units to new ownership.

The iSun corporate identity has been entirely erased from the marketplace. The former entity and its SunCommon subsidiary now operate under the name “Original Clean Energy,” while commercial operations continue under the “Legacy Power” brand. Since September 3, 2024, newly appointed management has overseen these rebranded operations, eliminating any remaining corporate connection to the iSun name.

Implications for Equity Holders

The company’s shares currently appear on trading platforms with “potentially delisted” status and trade exclusively on the Pink Sheets. The Chapter 7 conversion eliminates any remaining possibility of shareholder recovery, as liquidation proceedings prioritize creditor claims exclusively. Common stockholders will receive no distribution, formally closing the book on iSun as an investment opportunity.

Ad

iSun Stock: Buy or Sell?! New iSun Analysis from February 7 delivers the answer:

The latest iSun figures speak for themselves: Urgent action needed for iSun investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

iSun: Buy or sell? Read more here...

Tags: iSun
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Next Post
WiMi Hologram Cloud Stock

WiMi Unveils Quantum AI Breakthrough for Holographic Imaging

Alpine Immune Sciences Stock

Vertex's Billion-Dollar Bet on Alpine Immune Sciences: A Strategic Analysis

Marvell Technology Stock

Marvell Technology Shares Face Mounting Pressure

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com